Sonnet BioTherapeutics Holdings Inc

NASDAQ:SONN   3:59:34 PM EDT
0.27
0.00 (+1.18%)
Earnings Announcements

Sonnet Biotherapeutics Holdings Inc - QTRLY Loss Per Share $0.14

Published: 05/10/2022 11:21 GMT
Sonnet BioTherapeutics Holdings Inc (SONN) - Sonnet Biotherapeutics Holdings Inc - Qtrly Loss per Share $0.14.
Revenue is expected to be $0.05 Million
Adjusted EPS is expected to be -$0.14

Next Quarter Revenue Guidance is expected to be $0.05 Million
Next Quarter EPS Guidance is expected to be -$0.10

More details on our Analysts Page.